McKesson upgraded at Baird on Core Ventures deal after Q2 beat
Baird upgraded McKesson (NYSE:MCK) to outperform from neutral on Thursday, citing the updates the medical distributor gave ...
MarketWatch25m
McKesson Shares Jump After FY25 Outlook Boost, Strong 2Q Sales
Shares of McKesson climbed after the drug distributor raised its fiscal-year guidance and reported strong sales growth during its fiscal second quarter. The stock was up 11%, at $610.99, in midday ...
McKesson's Fiscal Q2 EPS Tops Forecast
McKesson's earnings for its fiscal 2025 second quarter exceeded expectations, despite special charges that cut into net ...
Stock market today: Wall Street ticks higher ahead of the Fed’s decision on interest rates
U.S. stocks are ticking higher ahead of the Federal Reserve’s announcement coming later in the afternoon about what it will ...
McKesson raises annual profit forecast on strength in its U.S. pharma segment
Drug distributor McKesson Corp raised its annual profit forecast on Wednesday, driven by increased sales in its U.S.
McKesson’s Strong Q2 Performance Leads to Upward EPS Revision, But Hold Rating Due to Segment Concerns and Uncertain Long-Term Growth
Steve Baxter, an analyst from Wells Fargo, maintained the Hold rating on McKesson (MCK – Research Report). The associated price target ...
McKesson’s Strong Financial Performance and Strategic Initiatives Justify Buy Rating
Morgan Stanley analyst Erin Wright has maintained their bullish stance on MCK stock, giving a Buy rating today. Erin Wright has given his Buy ...
UPI News on MSN2d
Medical supply company McKesson to pay more than $400K over discriminatory hiring
McKesson Medical-Surgical Inc. entered into an agreement with the Labor Department on Monday resolving employment ...
McKesson division pays nearly $450K in back wages for alleged hiring discrimination
The health care giant agreed to pay $448,000 in back wages to resolve hiring discrimination allegations at a DFW facility.
McKesson Corp (MCK) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...
McKesson Corp (MCK) reports a 21% revenue increase and raises fiscal 2025 EPS guidance amid strategic expansions and ...
What you need to know in Baltimore’s opioid case before it heads to jurors
Fletcher-Hill sends the case to the jury for consideration. Baltimore alleges that the companies, McKesson and AmerisourceBergen, flooded the city with hundreds of millions of addictive pain pills ...
Business Wire17h
McKesson Corporation Reports Fiscal 2025 Second Quarter Results and Raises Full Year Adjusted EPS Guidance
McKesson Corporation (NYSE: MCK) has released its fiscal 2025 second quarter financial results. Results can be accessed on McKesson’s Investor Relatio ...